Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 25, 2024 08:07 ET | Source: Cybrexa Therapeutics

Industry Leader John Maraganore, Ph.D., Joins Cybrexa Therapeutics as Strategic Advisor

NEW HAVEN, Conn., June 25, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
February 06, 2024 08:00 ET | Source: Cybrexa Therapeutics

Cybrexa Regains Rights to CBX-12

NEW HAVEN, Conn., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
August 08, 2023 04:00 ET | Source: Astex Pharmaceuticals

Astex Expands Drug Discovery Collaboration With MSD

CAMBRIDGE, United Kingdom, Aug. 08, 2023 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals (UK) (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule...
July 25, 2023 14:33 ET | Source: Persistence Market Research

Growing Emphasis on Generic Drug Manufacturing Boosts Active Pharmaceutical Ingredient Market to US$ 300.2 Billion by 2033: Persistence Market Research

New York, July 25, 2023 (GLOBE NEWSWIRE) -- Worldwide revenue from the active pharmaceutical ingredients market stands at US$ 192.3 Billion in 2022, with the global market estimated to surge ahead...
May 25, 2023 17:01 ET | Source: Cybrexa Therapeutics

Cybrexa Therapeutics To Present Data at ASCO 2023 Highlighting First-In-Human, Dose-Finding Study of Lead Candidate CBX-12

Activity and Safety Profile Reinforces Potential of CBX-12 in Solid TumorsFour Objective Responses Observed in Breast and Ovarian Cancers with CBX-12Dose-Limiting Toxicity Identified as...
April 12, 2023 08:00 ET | Source: Cybrexa Therapeutics

Cybrexa Appoints Jaya Gautam as Senior Vice President of Technical Operations

NEW HAVEN, Conn., April 12, 2023 (GLOBE NEWSWIRE) -- Cybrexa Therapeutics, a clinical-stage oncology biotechnology company developing a novel class of tumor-targeting peptide drug conjugate (PDC)...
January 24, 2023 09:15 ET | Source: CMI

Global Bio analytical Testing Services Market to Surpass US$ 7,749.5 Million by 2030, Says Coherent Market Insights (CMI)

Burlingame, Jan. 24, 2023 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, global bio analytical testing services market is estimated to be valued at US$ 3,198.9 million in 2022 and is...
October 03, 2022 06:30 ET | Source: Transparency Market Research

AI in Drug Discovery Market to Rise at 36.1% CAGR during Forecast Period: TMR Study

Wilmington, Delaware, United States, Oct. 03, 2022 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. – By 2031, the AI in drug discovery market size is estimated to surpass value of US$ 10.93...
November 30, 2021 08:56 ET | Source: Research Nester

Global Regenerative Medicine Market to Touch USD 167500.0 Million by 2029; Increasing Incidences of Cancer and Other Chronic Diseases to Create Opportunities for Market Growth

New York, Nov. 30, 2021 (GLOBE NEWSWIRE) -- According to the statistics by the American Institute of Cancer Research, the total number of new cases of cancer diagnosed worldwide in the year 2018 was...
October 06, 2021 07:00 ET | Source: Recro Pharma, Inc.

Recro Reports Inducement Grants For New Staff

EXTON, Penn. and SAN DIEGO, Oct. 06, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...

Next Page keyboard_arrow_right